Literature DB >> 8932435

Erythrocytes and the transport of drugs and endogenous compounds.

M S Highley1, E A De Bruijn.   

Abstract

This review considers the significance and measurement of endogenous compounds and drugs on erythrocytes. Part I examines literature examples where a direct measurement of hydrocortisone, phenytoin and valproate was performed on unwashed red cells in vitro and in vivo, showing a consistent contribution of the erythrocyte fraction to the transport of these compounds. In vitro partition experiments using systems composed of plasma water, plasma proteins and erythrocytes are discussed. When spiked blood is diluted with blank autologous plasma water, erythrocytes always discharge the compound over-proportionally compared to plasma proteins. In vivo, during the distribution phase, the elimination half-life from the erythrocyte is the same as or shorter than that from plasma water, and substantial amounts of drug leaving the circulation originate from erythrocytes. In Part II, the transfer of compounds is considered and evidence for the facilitated exchange of red cell associated substances between the erythrocyte and capillary endothelium presented. Situations where a failure to analyse the erythrocyte compartment leads to the loss of vital information are identified. Part III explores methods for analysing erythrocyte associated substances, most commonly indirect calculation, or analysis of washed erythrocytes. A direct determination is rarely performed, but one such method, allowing concurrent plasma analysis, is discussed. An instrument collects a fixed and known quantity of a maximally compressed cell mass, without disturbing the equilibrium between cells and plasma. To isolate compounds associated with the mass of erythrocytes, the red cell sediment can often be extracted quantitatively into a blank protein solution.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8932435     DOI: 10.1023/a:1016074627293

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  48 in total

1.  A major inhibitor of phenytoin binding to serum protein in uremia.

Authors:  H Mabuchi; H Nakahashi
Journal:  Nephron       Date:  1988       Impact factor: 2.847

2.  Pentazocine binding to blood cells and plasma proteins.

Authors:  M Ehrnebo; S Agurell; L O Boréus; E Gordon; U Lönroth
Journal:  Clin Pharmacol Ther       Date:  1974-09       Impact factor: 6.875

3.  Preferential location of circulating activated cyclophosphamide within the erythrocyte.

Authors:  M S Highley; P G Harper; P H Slee; E DeBruijn
Journal:  Int J Cancer       Date:  1996-03-01       Impact factor: 7.396

4.  Blood-brain barrier transport of CI-912: single-passage equilibration of erythrocyte-borne drug.

Authors:  E M Cornford; K P Landon
Journal:  Ther Drug Monit       Date:  1985       Impact factor: 3.681

5.  Influence of food on the absorption of phenytoin in man.

Authors:  A Melander; G Brante; O Johansson; T Lindberg; E Wåhlin-Boll
Journal:  Eur J Clin Pharmacol       Date:  1979-05-21       Impact factor: 2.953

6.  Testosterone transport in brain: primary role of plasma protein-bound hormone.

Authors:  W M Pardridge; E M Landaw
Journal:  Am J Physiol       Date:  1985-11

7.  Anticancer activities of adenine nucleotides in mice are mediated through expansion of erythrocyte ATP pools.

Authors:  E Rapaport; J Fontaine
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

8.  Folate status of Mexican American, Cuban, and Puerto Rican women.

Authors:  M T Fanelli-Kuczmarski; C L Johnson; L Elias; M F Najjar
Journal:  Am J Clin Nutr       Date:  1990-08       Impact factor: 7.045

9.  Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemia.

Authors:  J S Lilleyman; L Lennard
Journal:  Lancet       Date:  1994-05-14       Impact factor: 79.321

10.  Trapped plasma in the microhematocrit.

Authors:  T C Pearson; D L Guthrie
Journal:  Am J Clin Pathol       Date:  1982-11       Impact factor: 2.493

View more
  14 in total

1.  Simulation of the pharmacokinetic profile of methazolamide in blood: effect of erythrocyte carbonic anhydrase binding on drug disposition.

Authors:  Malaz A AbuTarif; David R Taft
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

Review 2.  Role of red blood cells in pharmacokinetics of chemotherapeutic agents.

Authors:  Dirk Schrijvers
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  Dendrimer interactions with hydrophobic fluorescent probes and human serum albumin.

Authors:  D Shcharbin; B Klajnert; V Mazhul; M Bryszewska
Journal:  J Fluoresc       Date:  2005-01       Impact factor: 2.217

Review 4.  Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites.

Authors:  T Kerbusch; J de Kraker; H J Keizer; J W van Putten; H J Groen; R L Jansen; J H Schellens; J H Beijnen
Journal:  Clin Pharmacokinet       Date:  2001-01       Impact factor: 6.447

5.  Biogenic and synthetic polyamines bind bovine serum albumin.

Authors:  S Dubeau; P Bourassa; T J Thomas; H A Tajmir-Riahi
Journal:  Biomacromolecules       Date:  2010-06-14       Impact factor: 6.988

6.  In vitro characterization of the erythrocyte distribution of methazolamide: a model of erythrocyte transport and binding kinetics.

Authors:  G R Iyer; R A Bellantone; D R Taft
Journal:  J Pharmacokinet Biopharm       Date:  1999-02

7.  Differences in lipoprotein lipid concentration and composition modify the plasma distribution of cyclosporine.

Authors:  K M Wasan; P H Pritchard; M Ramaswamy; W Wong; E M Donnachie; L J Brunner
Journal:  Pharm Res       Date:  1997-11       Impact factor: 4.200

8.  Development and validation of a sensitive assay for the quantification of imatinib using LC/LC-MS/MS in human whole blood and cell culture.

Authors:  Jelena Klawitter; Yan Ling Zhang; Jost Klawitter; Nora Anderson; Natalie J Serkova; Uwe Christians
Journal:  Biomed Chromatogr       Date:  2009-12       Impact factor: 1.902

9.  Clinical validation and implications of dried blood spot sampling of carbamazepine, valproic acid and phenytoin in patients with epilepsy.

Authors:  Sing Teang Kong; Shih-Hui Lim; Wee Beng Lee; Pasikanthi Kishore Kumar; Hwee Yi Stella Wang; Yan Lam Shannon Ng; Pei Shieen Wong; Paul C Ho
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

10.  Facilitated uptake of a bioactive metabolite of maritime pine bark extract (pycnogenol) into human erythrocytes.

Authors:  Max Kurlbaum; Melanie Mülek; Petra Högger
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.